A citation-based method for searching scientific literature

Nelson G Ordóñez. Appl Immunohistochem Mol Morphol 2014
Times Cited: 15







List of co-cited articles
59 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity




Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group.
Aliya Noor Husain, Thomas V Colby, Nelson G Ordóñez, Timothy Craig Allen, Richard Luther Attanoos, Mary Beth Beasley, Kelly Jo Butnor, Lucian R Chirieac, Andrew M Churg, Sanja Dacic,[...]. Arch Pathol Lab Med 2018
242
33

Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma.
Albert Y Chu, Leslie A Litzky, Theresa L Pasha, Geza Acs, Paul J Zhang. Mod Pathol 2005
190
20



Mesothelial markers in high-grade breast carcinoma.
Edwina E Duhig, Lydia Kalpakos, Ian A Yang, Belinda E Clarke. Histopathology 2011
14
21


Low calretinin expression and high neutrophil-to-lymphocyte ratio are poor prognostic factors in patients with malignant mesothelioma undergoing extrapleural pneumonectomy.
Steven Chuan-Hao Kao, Sonja Klebe, Douglas W Henderson, Glen Reid, Mark Chatfield, Nicola J Armstrong, Tristan D Yan, Janette Vardy, Stephen Clarke, Nico van Zandwijk,[...]. J Thorac Oncol 2011
65
20

Calretinin: a novel immunocytochemical marker for mesothelioma.
C Doglioni, A P Dei Tos, L Laurino, P Iuzzolino, C Chiarelli, M R Celio, G Viale. Am J Surg Pathol 1996
361
20

Calretinin expression in high-grade invasive ductal carcinoma of the breast is associated with basal-like subtype and unfavorable prognosis.
Ross J Taliano, Shaolei Lu, Kamaljeet Singh, Shamlal Mangray, Rose Tavares, Lelia Noble, Murray B Resnick, Evgeny Yakirevich. Hum Pathol 2013
15
20

Mesothelin-family proteins and diagnosis of mesothelioma.
Bruce W S Robinson, Jenette Creaney, Richard Lake, Anna Nowak, A William Musk, Nick de Klerk, Pernilla Winzell, Karl Erik Hellstrom, Ingegerd Hellstrom. Lancet 2003
401
20

Development of an enzyme-linked immunosorbent assay for the detection of human calretinin in plasma and serum of mesothelioma patients.
Irina Raiko, Ingrid Sander, Daniel G Weber, Monika Raulf-Heimsoth, Adrian Gillissen, Jens Kollmeier, Arnaud Scherpereel, Thomas Brüning, Georg Johnen. BMC Cancer 2010
22
20

Calretinin as a blood-based biomarker for mesothelioma.
Georg Johnen, Katarzyna Gawrych, Irina Raiko, Swaantje Casjens, Beate Pesch, Daniel G Weber, Dirk Taeger, Martin Lehnert, Jens Kollmeier, Torsten Bauer,[...]. BMC Cancer 2017
23
20

HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma.
Shoutaro Tsuji, Kota Washimi, Taihei Kageyama, Makiko Yamashita, Mitsuyo Yoshihara, Rieko Matsuura, Tomoyuki Yokose, Yoichi Kameda, Hiroyuki Hayashi, Takao Morohoshi,[...]. Sci Rep 2017
27
20


Claudin 4 identifies a wide spectrum of epithelial neoplasms and represents a very useful marker for carcinoma versus mesothelioma diagnosis in pleural and peritoneal biopsies and effusions.
Fabio Facchetti, Silvia Lonardi, Francesca Gentili, Luisa Bercich, Marcella Falchetti, Regina Tardanico, Carla Baronchelli, Laura Lucini, Alessandro Santin, Bruno Murer. Virchows Arch 2007
79
13

D2-40 and calretinin - a tissue microarray analysis of 341 malignant mesotheliomas with emphasis on sarcomatoid differentiation.
Marc Hinterberger, Tanja Reineke, Martina Storz, Walter Weder, Peter Vogt, Holger Moch. Mod Pathol 2007
57
13





Expression of calretinin by breast carcinoma and the potential for misdiagnosis of mesothelioma.
George Powell, Heather Roche, William R Roche. Histopathology 2011
19
13

Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma.
Kei Kushitani, Yukio Takeshima, Vishwa Jeet Amatya, Osamu Furonaka, Akio Sakatani, Kouki Inai. Pathol Int 2007
76
13

Functional inactivation of NF2/merlin in human mesothelioma.
Claudio Thurneysen, Isabelle Opitz, Stefanie Kurtz, Walter Weder, Rolf A Stahel, Emanuela Felley-Bosco. Lung Cancer 2009
93
13

CD74: a new prognostic factor for patients with malignant pleural mesothelioma.
C Otterstrom, A Soltermann, I Opitz, E Felley-Bosco, W Weder, R A Stahel, F Triponez, J H Robert, V Serre-Beinier. Br J Cancer 2014
18
13


The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments.
Stephen A Bustin, Vladimir Benes, Jeremy A Garson, Jan Hellemans, Jim Huggett, Mikael Kubista, Reinhold Mueller, Tania Nolan, Michael W Pfaffl, Gregory L Shipley,[...]. Clin Chem 2009
13

Induction of senescence markers after neo-adjuvant chemotherapy of malignant pleural mesothelioma and association with clinical outcome: an exploratory analysis.
Roy Sidi, Giulia Pasello, Isabelle Opitz, Alex Soltermann, Michaela Tutic, Hubert Rehrauer, Walter Weder, Rolf A Stahel, Emanuela Felley-Bosco. Eur J Cancer 2011
39
13

Role of hedgehog signaling in malignant pleural mesothelioma.
Yandong Shi, Ubiratan Moura, Isabelle Opitz, Alex Soltermann, Hubert Rehrauer, Svenja Thies, Walter Weder, Rolf A Stahel, Emanuela Felley-Bosco. Clin Cancer Res 2012
44
13

Establishment and characterization of five human malignant mesothelioma cell lines derived from pleural effusions.
L S Manning, D Whitaker, A R Murch, M J Garlepp, M R Davis, A W Musk, B W Robinson. Int J Cancer 1991
78
13

Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients.
Noriyasu Usami, Takayuki Fukui, Masashi Kondo, Tetsuo Taniguchi, Toshihiko Yokoyama, Shoichi Mori, Kohei Yokoi, Yoshitsugu Horio, Kaoru Shimokata, Yoshitaka Sekido,[...]. Cancer Sci 2006
106
13

Calretinin: modulator of neuronal excitability.
Aaron James Camp, Rajiv Wijesinghe. Int J Biochem Cell Biol 2009
67
13

Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales.
A Linton, N Pavlakis, R O'Connell, M Soeberg, S Kao, S Clarke, J Vardy, N van Zandwijk. Br J Cancer 2014
47
13

Calretinin expression in human normal and neoplastic tissues: a tissue microarray analysis on 5233 tissue samples.
Alessandro Lugli, Yvonne Forster, Philippe Haas, Antoinio Nocito, Christoph Bucher, Heidi Bissig, Martina Mirlacher, Martina Storz, Michael J Mihatsch, Guido Sauter. Hum Pathol 2003
122
13

Biomarker research with prospective study designs for the early detection of cancer.
B Pesch, T Brüning, G Johnen, S Casjens, N Bonberg, D Taeger, A Müller, D G Weber, T Behrens. Biochim Biophys Acta 2014
36
13

Malignant pleural mesothelioma: an epidemiological perspective.
Benjamin M Robinson. Ann Cardiothorac Surg 2012
162
13

Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions.
Harvey I Pass, Anil Wali, Naimei Tang, Alla Ivanova, Sergey Ivanov, Michael Harbut, Michele Carbone, Jeffrey Allard. Ann Thorac Surg 2008
103
13

Assessment of Confounding Factors Affecting the Tumor Markers SMRP, CA125, and CYFRA21-1 in Serum.
Daniel Gilbert Weber, Georg Johnen, Dirk Taeger, Anne Weber, Isabelle Mercedes Gross, Beate Pesch, Thomas Kraus, Thomas Brüning, Monika Gube. Biomark Insights 2010
19
13

Glomerular filtration rate is a confounder for the measurement of soluble mesothelin in serum.
Kevin Hollevoet, Dirk Bernard, Frank De Geeter, Natascha Walgraeve, Anja Van den Eeckhaut, Raymond Vanholder, Christophe Van de Wiele, Veronique Stove, Jan P van Meerbeeck, Joris R Delanghe. Clin Chem 2009
27
13

Peritoneal malignant mesothelioma (PMM), and primary peritoneal serous carcinoma (PPSC) and reactive mesothelial hyperplasia (RMH) of the peritoneum. Immunohistochemical and fluorescence in situ hybridisation (FISH) analyses.
Toshiaki Kawai, Susumu Tominaga, Sadayuki Hiroi, Sho Ogata, Kuniaki Nakanishi, Kunimitsu Kawahara, Hiroshi Sonobe, Kenzo Hiroshima. J Clin Pathol 2016
18
13

PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma.
Anna R Laury, Jason L Hornick, Ruth Perets, Jeffrey F Krane, Joseph Corson, Ronny Drapkin, Michelle S Hirsch. Am J Surg Pathol 2010
137
13


Intracellular calcium-binding proteins: more sites than insights.
C W Heizmann, W Hunziker. Trends Biochem Sci 1991
409
13

MUC4 immunohistochemistry is useful in distinguishing epithelioid mesothelioma from adenocarcinoma and squamous cell carcinoma of the lung.
Amany Sayed Mawas, Vishwa Jeet Amatya, Kei Kushitani, Yuichiro Kai, Yoshihiro Miyata, Morihito Okada, Yukio Takeshima. Sci Rep 2018
11
18

Value of immunohistochemistry in the differential diagnosis of pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma.
Yukio Takeshima, Vishwa J Amatya, Kei Kushitani, Mayumi Kaneko, Kouki Inai. Histopathology 2009
43
13


Sarcomatoid mesothelioma and its histological mimics: a comparative immunohistochemical study.
D R Lucas, H I Pass, S K Madan, N V Adsay, A Wali, P Tabaczka, F Lonardo. Histopathology 2003
94
13

Utility and pitfalls of immunohistochemistry in the differential diagnosis between epithelioid mesothelioma and poorly differentiated lung squamous cell carcinoma.
Kei Kushitani, Vishwa J Amatya, Yasuko Okada, Yuya Katayama, Amany S Mawas, Yoshihiro Miyata, Morihito Okada, Kouki Inai, Takumi Kishimoto, Yukio Takeshima. Histopathology 2017
16
13

Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma.
Michele Carbone, David Shimizu, Andrea Napolitano, Mika Tanji, Harvey I Pass, Haining Yang, Sandra Pastorino. Oncotarget 2016
41
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.